China Pharma Holdings (CPHI) Other Non Operating Income (2010 - 2011)
China Pharma Holdings' (CPHI) quarterly Other Non Operating Income came in at $256762.0 in Q2 2011, down 68.18% YoY from $807005.0 in Q2 2010, and down 62.1% on a QoQ basis from $677498.0 in Q1 2011.
China Pharma Holdings (CPHI) Other Non Operating Income (2010 - 2011) Analysis & Trends
China Pharma Holdings (CPHI) has 2 years of Other Non Operating Income data on file, last reported at $256762.0 in Q2 2011.
- Quarterly Other Non Operating Income fell 68.18% year-over-year to $256762.0 in Q2 2011, while the trailing twelve-month figure through Mar 2012 was $256762.0 (down 84.97% YoY) and the FY2011 annual result came in at $934260.0, down 41.2% from the prior year.
- Other Non Operating Income eased to $256762.0 in Q2 2011, from $677498.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $807005.0 in Q2 2010 to a low of -$206308.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | China Pharma Holdings | 42.55 Mn | 42.24 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 256,762.00 |
| Mar 31, 2011 | 677,498.00 |
| Dec 31, 2010 | -206,308.00 |
| Sep 30, 2010 | 429,687.00 |
| Jun 30, 2010 | 807,005.00 |